Neuronetics Inc.
Neuronetics Inc. (STIM): 3 pipeline candidates · ~9 mo cash runway · 5 clinical trials. Updated within the last hour.
BioSniper Score
5-factor signal · derived from public data
8.7 months
D/E 8.17 · 0% dilution
Lead: Approved
3 candidates
N/A
12 buys · 10 sells (180d)
A transparent, data-derived signal for Neuronetics Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$87.7M
Cash
$19.0M
Quarterly Burn
$9.4M
Runway
8.7 mo
Revenue
$34.5M
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (3 candidates)
| Drug | Phase |
|---|---|
| neurostar advanced therapy system | Approved |
| neurostar tms system | — |
| neurostar tms system | — |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
96
Total value held
$29.7M
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 4,095,950 | $5.9M |
| balyasny asset management l.p. | 2,743,768 | $4.0M |
| blackrock, inc. | 2,318,537 | $3.4M |
| fourworld capital management llc | 1,489,322 | $2.2M |
| masters capital management llc | 1,000,000 | $1.4M |
| geode capital management, llc | 958,989 | $1.4M |
| state street corp | 842,547 | $1.2M |
| ikarian capital, llc | 701,182 | $1.0M |
| wexford capital lp | 700,961 | $1.0M |
| advisorshares investments llc | 617,193 | $895K |
Showing top 10 of 96 institutional holders of Neuronetics Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in Neuronetics Inc.'s pipeline?
Neuronetics Inc. (STIM) has 3 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Neuronetics Inc.'s lead drug candidate?
Neuronetics Inc.'s most advanced tracked candidate is neurostar advanced therapy system (Approved) for Major depressive disorder (MDD), obsessive-compulsive disorder (OCD), and anxious depression.
What is Neuronetics Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Neuronetics Inc. has approximately 8.7 months of cash runway.
What is Neuronetics Inc.'s market capitalization?
Neuronetics Inc.'s market capitalization is approximately $87.7M.
Who is the CEO of Neuronetics Inc.?
Mr. Daniel L. Reuvers is the chief executive officer of Neuronetics Inc. (STIM).
Get the full picture on Neuronetics Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.